Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
OR ›
ORTHOBIOLOGICS REIMAGINED
Trademark search for:
ORTHOBIOLOGICS REIMAGINED
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-08-29 — Application filed
2019-09-02 — Application filed
2019-09-11 — Application filed
2019-12-03 — Final disposition recorded
2019-12-03 — Final disposition recorded
2019-12-03 — Assigned to examiner
2019-12-03 — Final disposition recorded
2020-06-02 — Office action issued
2020-06-02 — Correspondence received in law office
2020-06-03 — Teas/email correspondence entered
2020-06-04 — Approved for pub - principal register
2020-06-17 — Notification of notice of publication e-mailed
2020-07-07 — Published for opposition
2020-07-07 — Official gazette publication confirmation e-mailed
2020-09-01 — Noa e-mailed - sou required from applicant
2021-02-26 — Sou teas extension received
2021-02-26 — Sou extension 1 filed
2021-02-26 — Sou extension 1 granted
2021-03-02 — Notice of approval of extension request e-mailed
2021-08-16 — Sou teas extension received
2021-08-16 — Sou extension 2 filed
2021-08-16 — Sou extension 2 granted
2021-08-18 — Notice of approval of extension request e-mailed
2022-02-08 — Sou teas extension received
2022-02-08 — Sou extension 3 filed
2022-02-08 — Sou extension 3 granted
2022-02-10 — Notice of approval of extension request e-mailed
2022-08-18 — Sou teas extension received
2022-08-18 — Sou extension 4 granted
2022-08-18 — Sou extension 4 filed
2022-08-20 — Notice of approval of extension request e-mailed
2023-02-02 — Sou teas extension received
2023-02-02 — Sou extension 5 filed
2023-02-21 — Case assigned to intent to use paralegal
2023-02-21 — Sou extension 5 granted
2023-02-22 — Notice of approval of extension request e-mailed
2023-10-02 — Application abandoned
2023-10-02 — Application abandoned
2023-10-02 — Final status recorded
Owner Information
Regenacell Therapy, Inc.
Regenacell Therapy, Inc.
Correspondent
Arvid von Taube RICH MAY, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
